LON:OBI Ondine Biomedical (OBI) Share Price, News & Analysis GBX 8.38 +0.38 (+4.75%) (As of 10/31/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsHeadlines About Ondine Biomedical Stock (LON:OBI) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Ondine Biomedical alerts:Sign Up Key Stats Today's Range 8▼ 8.7550-Day Range 5.50▼ 8.5052-Week Range 4.50▼ 15.88Volume170,379 shsAverage Volume259,764 shsMarket Capitalization£23.22 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewOndine Biomedical Inc., a Life sciences company, engages in the research, development, and commercialization of antimicrobial photodisinfection therapies in Canada and internationally. Its product platform is Photodisinfection, a topical light-based antimicrobial technology that eliminates harmful pathogens. The company's lead product is Steriwave, a photodisinfection-based medical device that eliminates harmful nasal pathogens, which leads to healthcare-associated infections. Its product pipeline also includes development of a topical antiviral therapy for the upper respiratory tract that reduces viral titres and transmission of respiratory viruses, such as SARS-CoV-2, influenza, RSV, etc.; a solution for treatment of chronic rhinosinusitis; a solution for disinfection of endotracheal tubes to reduce the incidence of ventilator-associated pneumonia; and a solution for decolonization of burns and wounds. The company was incorporated in 1996 and is headquartered in Vancouver, Canada.Read More… The real reason Elon is fully endorsing Trump (Ad)Elon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to humanity, there is a war being waged on Elon Musk. This war has nothing to do with X, Elon’s stance on immigration or his support for Donald Trump. Watch this new documentary and you’ll discover what Elon knows, Receive OBI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Ondine Biomedical and its competitors with MarketBeat's FREE daily newsletter. Email Address OBI Stock News HeadlinesOndine Continues Commercial GrowthOctober 29 at 4:22 AM | uk.finance.yahoo.comOndine Biomedical (LON:OBI) Stock Price Up 11.7% - What's Next?October 26, 2024 | americanbankingnews.comThe most serious warning of my careerWith the 2024 election just weeks away, a new crisis is barrelling down on America… one that could cleave the financial world in two the moment the polls close. I predict they could see investment losses of 50% (or more) in the weeks following the presidential election. October 31, 2024 | Porter & Company (Ad)Ondine Biomedical Inc. Announces King's College Hospital to Run Steriwave PilotOctober 23, 2024 | uk.finance.yahoo.comOndine Biomedical Reports Robust Growth in H1 2024September 30, 2024 | uk.finance.yahoo.comOBIMF Ondine Biomedical Inc.September 27, 2024 | seekingalpha.comOndine Biomedical Inc. Announces Collaboration advances Steriwave for ICU MarketSeptember 26, 2024 | uk.finance.yahoo.comLONDON MARKET MIDDAY: Stocks higher ahead of US data after China boostSeptember 24, 2024 | lse.co.ukSee More Headlines OBI Stock Analysis - Frequently Asked Questions How have OBI shares performed this year? Ondine Biomedical's stock was trading at GBX 8.75 at the beginning of 2024. Since then, OBI shares have decreased by 4.3% and is now trading at GBX 8.38. View the best growth stocks for 2024 here. How do I buy shares of Ondine Biomedical? Shares of OBI stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. What other stocks do shareholders of Ondine Biomedical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Ondine Biomedical investors own include AutoZone (AZO), Intel (INTC), Premier African Minerals (PREM), Rolls-Royce Holdings plc (RR), TJX Companies (TJX), Abacus Health Products (ABAHF) and Aurora Cannabis (ACB). Industry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolLON:OBI CUSIPN/A CIKN/A Webwww.ondinebio.com Phone604-669-0555FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX (0.03) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income£-14,270,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-685.59% Return on Assets-159.71% Debt Debt-to-Equity Ratio1,847.37 Current Ratio0.80 Quick Ratio8.26 Sales & Book Value Annual Sales£1.63 million Price / Sales14.25 Cash FlowGBX 4.21 per share Price / Cash Flow1.99 Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares277,290,000Free FloatN/AMarket Cap£23.22 million OptionableNot Optionable Beta0.10 (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report This page (LON:OBI) was last updated on 10/31/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsoredtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored“Buffett Indicator” Predicts 62% Stock Market CrashThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | SponsoredTrump or Kamala? It may come down to this strange twist…Could this be the key to America's second coming? A strange resurrection born in the hollers of Appalachia? ...Porter & Company | Sponsored625,000% GainThe recent pullback in the crypto markets has left many investors in full-on panic mode, convinced the bull ru...Crypto Swap Profits | SponsoredGold at $2,600... But This Stock Gives You More for Under $20Gold just soared over $2,600 an ounce. But what if I told you there's a way to get exposure to MORE than an...Monument Traders Alliance | SponsoredCNBC’s ‘Prophet’ issues urgent Fed warning"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ondine Biomedical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ondine Biomedical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.